相关实验视频
Updated: Sep 11, 2025

05:39
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
205
接受杜维利西布单剂和组合疗法的患者的皮肤学不良事件
Viviane Liao1, Nivetha Ganesan1, Stephen Dusza1
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Clinical lymphoma, myeloma & leukemia
|August 17, 2025
概括
与其他药物结合使用杜维利西布,可显著减少T细胞淋巴瘤患者皮肤学不良事件 (DAE). 组合疗法使患者能够更有效地继续杜维利西布治疗,而不是单剂使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 杜维利西布是一种双酸酸3激酶 (PI3K) -γ和 -δ抑制剂,已被批准用于某些白血病,并且对T细胞淋巴瘤有希望.
- 关于杜维利西布特异性皮肤学不良事件 (DAE) 的数据有限,尽管已知其他PI3K抑制剂的DAE.
研究的目的:
- 在T细胞淋巴瘤患者中,以回顾性地描述与杜维利西布相关的DAE.
- 为了比较单剂杜维利西布和组合疗法之间的DAE发病率.
主要方法:
- 在2000年至2024年期间,对173名用杜维利西布治疗的患者进行了回顾性分析.
- 评估可能的,可能的或确定的杜维利西布相关的DAE.
- 在不同杜维利西布治疗方案中对DAE率的比较.
主要成果:
- 单剂杜维利西布的DAE总发病率为31.9%,组合疗法为18.6%至5.7%.
- 斑点斑点性皮疹,疹和粘膜炎是最常见的DAE.
- 组合疗法显著降低了DAE发病率 (P = .004) 和因DAE而中止治疗 (P < .05).
- 停药后发生的疹发生在5.8%的组合治疗患者中,包括一个史蒂文斯-约翰逊综合征病例.
结论:
- 将杜维利西布与罗米德素,博特佐米布或鲁克索利提尼布结合使用,可降低DAE发生率并改善治疗坚持.
- 需要进一步的研究来了解组合药物对PI3K抑制剂相关的DAE的影响.
相关概念视频
Allergic Drug Reactions
979
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
979
Skin Diseases and Disorders
4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Skin Cancer
4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
Insulin: Dosing Regimen and Adverse Effects
259
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
259
Drug Administration and Therapy Phases: Overview
743
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
743

